• Policy
• Decreased commitment to production/sales/new generics
• by Lee, Jeong-Hwan Apr 13, 2023 05:45am

• Company
• Supreme Court dismissed again
• by Chon, Seung-Hyun Apr 13, 2023 05:44am

• Company
• SK Bioscience declares its vision
• by Kim, Jin-Gu Apr 13, 2023 05:43am

• InterView
• Samsung Bio, investing in Swiss ADC bio company
• by Hwang, Jin-joon Apr 13, 2023 05:43am

• Company
• LSK's contracts for early-phase clinical trials increase
• by Lee, Tak-Sun Apr 12, 2023 05:54am

• Policy
• The results of the PVA improvement plan study were disclosed
• by Lee, Tak-Sun Apr 12, 2023 05:54am

• Policy
• 16% of PVA-applied products cut more than 2 times
• by Lee, Tak-Sun Apr 12, 2023 05:54am

• Company
• PharmaEssentia attempts to reimb its first new drug BESREMi
• by Eo, Yun-Ho Apr 12, 2023 05:53am

• Policy
• The alternative drug pricing system will be improved
• by Nho, Byung Chul Apr 12, 2023 05:53am

• Policy
• Leukemia Scemblix·Onureg passed the Evaluation Committee
• by Lee, Tak-Sun Apr 11, 2023 06:11am